Peters Frank T, Samyn Nele, Kraemer Thomas, Riedel Wim J, Maurer Hans H
Department of Experimental and Clinical Toxicology, Saarland University, Homburg (Saar), Germany.
Clin Chem. 2007 Apr;53(4):702-10. doi: 10.1373/clinchem.2006.081547. Epub 2007 Mar 1.
Enantioselective analysis of amphetamine (AM), methamphetamine (MA), 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA), and 3,4-methylenedioxyethylamphetamine (MDEA) helps interpret toxicological results. Methods have been described for various matrices, but so far not for oral fluid, a matrix of increasing importance in testing for drugs of abuse, especially in the context of driving under the influence of drugs (DUID).
After dilution with 200 microL carbonate buffer (pH 9), oral fluid samples (10-50 microL) were derivatized with S-heptafluorobutyrylprolyl chloride. The resulting diastereomers were extracted into 100 microL of cyclohexane, separated by gas chromatography (HP-5MS column), and detected by mass spectrometry in the negative-ion chemical ionization mode (GC-NICI-MS). The method was validated and applied to samples from a controlled study with MDMA and from authentic DUID cases.
The derivatized AM, MA, MDA, MDMA, and MDEA enantiomers were well separated from each other. The method was linear from 5-250 microg/L per enantiomer of MDA and from 25-1250 microg/L per enantiomer of AM, MA, MDMA, and MDEA. With the exception of MDEA, analytical recoveries, repeatability, and intermediate precision were within required limits. The analyte concentrations and enantiomer ratios in the application samples correlated only weakly with corresponding published plasma data.
This sensitive, reliable, and fast GC-NICI-MS assay enantioselectively measures AM, MA, MDA, and MDMA in oral fluid samples. Prediction of plasma concentrations and enantiomer ratios from respective oral fluid data is not possible.
对苯丙胺(AM)、甲基苯丙胺(MA)、3,4-亚甲基二氧基苯丙胺(MDA)、3,4-亚甲基二氧基甲基苯丙胺(MDMA)和3,4-亚甲基二氧基乙基苯丙胺(MDEA)进行对映体选择性分析有助于解释毒理学结果。已针对各种基质描述了相关方法,但迄今为止尚未针对口腔液进行描述,口腔液在滥用药物检测中,尤其是在药物影响下驾驶(DUID)的背景下,是一种越来越重要的基质。
用200微升碳酸盐缓冲液(pH 9)稀释后,将口腔液样本(10 - 50微升)用S-七氟丁酰基脯氨酰氯进行衍生化。所得非对映异构体用100微升环己烷萃取,通过气相色谱(HP - 5MS柱)分离,并在负离子化学电离模式(GC - NICI - MS)下用质谱检测。该方法经过验证,并应用于MDMA对照研究和真实DUID病例的样本。
衍生化的AM、MA、MDA、MDMA和MDEA对映体彼此分离良好。该方法对于MDA的每个对映体在5 - 250微克/升范围内呈线性,对于AM、MA、MDMA和MDEA的每个对映体在25 - 1250微克/升范围内呈线性。除MDEA外,分析回收率、重复性和中间精密度均在规定限度内。应用样本中的分析物浓度和对映体比例与相应已发表的血浆数据仅存在微弱相关性。
这种灵敏、可靠且快速的GC - NICI - MS测定法可对映体选择性地测定口腔液样本中的AM、MA、MDA和MDMA。无法根据各自的口腔液数据预测血浆浓度和对映体比例。